Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: billkirn who wrote (3449)	12/29/1997 8:37:00 PM
From: JOHN W.	Read Replies (1) \| Respond to of 6136

Bill, yes I have been buying more btwn 28-30. Maybe it is my rose-colored glasses. Your last post sounded that you have changed your opinion considerably and view AGPH as a much higher risk. That is too bad. Short interest was interestingly unchanged: 11/14: 7,087,570 12/15: 6,903,411 for a -2.6% change. I would have thought there would be more short covering. Either these well informed investors still see much more downside or they are waiting to the year is over, I don' know. Any Ideas? If you see so much more risk now after Roche and now the info on Lilly about their Gart inhibitor, why did you buy more at 28? Has your long term (3-5 yrs) outlook changed?